` Comparison: O7PA, AMGN - Alpha Spread

N
O7PA
vs
AMGN

Over the past 12 months, O7PA has underperformed AMGN, delivering a return of 0% compared to the AMGN's +25% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
O7PA
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

N
O7PA Intrinsic Value
Not Available
AMGN Intrinsic Value
294.56 USD
Overvaluation 10%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
N
NeuBase Therapeutics Inc
F:O7PA
3.18 EUR
Amgen Inc
NASDAQ:AMGN
326.84 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
O7PA, AMGN

O7PA
AMGN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
N
NeuBase Therapeutics Inc
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
O7PA, AMGN

O7PA
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
N
NeuBase Therapeutics Inc
F:O7PA
Amgen Inc
NASDAQ:AMGN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

O7PA
0%
AMGN
72.1%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

Operating Margin

O7PA
0%
AMGN
33.6%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

Net Margin

O7PA
0%
AMGN
19.5%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

FCF Margin

O7PA
0%
AMGN
36.5%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

ROE

O7PA
-84.9%
AMGN
81.7%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

ROA

O7PA
-53.5%
AMGN
7.7%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

ROIC

O7PA
-198.4%
AMGN
14.6%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

ROCE

O7PA
-63%
AMGN
17.4%
LTM 3Y Avg 5Y Avg 10Y Avg
N
NeuBase Therapeutics Inc
Amgen Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
O7PA, AMGN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
O7PA, AMGN

Loading
O7PA
AMGN
Difference
www.alphaspread.com

Performance By Year
O7PA, AMGN

Loading
O7PA
AMGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare O7PA to other stocks
Unlock Full Access to Alpha Spread
Create Free Account